Chemotherapy Influences the Pseudocapsule Composition in Soft Tissue Sarcomas
- 1 March 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics and Related Research
- Vol. 472 (3), 849-855
- https://doi.org/10.1007/s11999-013-3022-7
Abstract
Soft tissue sarcomas are a heterogeneous group of malignant tumors. Standard treatment for soft tissue sarcoma of the extremity is surgical excision and adjuvant therapy; however, the role of neoadjuvant chemotherapy is controversial. We sought to (1) define the histologic characteristics of the pseudocapsule in soft tissue sarcomas; (2) compare the appearance of this structure in chemotherapy-treated versus untreated soft tissue sarcomas; and (3) evaluate the effect of chemotherapy on the presence and viability of tumor cells at the host-sarcoma interface. Twenty-eight patients with biopsy-proven, deep, high-grade extremity soft tissue sarcomas greater than 5 cm (AJCC stage III) treated with chemotherapy and surgical excision were compared histologically with 47 matched control subjects treated with surgery alone. A pseudocapsule was identifiable in the majority of tumors and consisted of two identifiable layers, each with specific histological characteristics suggesting the biologic processes occurring in these layers are different. The pseudocapsule was more frequently observed in the group treated with chemotherapy and it was more frequently continuous, thicker, and better developed in this group. Chemotherapy decreased the number of tumors with malignant cells identified within and beyond the pseudocapsule. Neoadjuvant chemotherapy contributed to the development of a pseudocapsule and decreased the number of tumors with malignant cells identified within and beyond the pseudocapsule. These findings may provide a histological explanation for the clinical effect of chemotherapy in soft tissue sarcoma. Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.Keywords
This publication has 18 references indexed in Scilit:
- Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF‐α and melphalanJournal of Surgical Oncology, 2011
- Hallmarks of cancer: Interactions with the tumor stromaExperimental Cell Research, 2010
- Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma GroupAnnals Of Oncology, 2009
- Evaluation of 47 Soft Tissue Sarcoma Resection Specimens after Isolated Limb Perfusion with TNF-α and Melphalan: Histologically Characterized Improved Margins Correlate with Absence of RecurrencesAnnals of Surgical Oncology, 2009
- A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for PatientsClinical Cancer Research, 2008
- Impact of Intensity-Modulated Radiation Therapy on Local Control in Primary Soft-Tissue Sarcoma of the ExtremityJournal of Clinical Oncology, 2008
- Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue SarcomaAnnals of Surgical Oncology, 2006
- Extremity soft tissue sarcoma: Evidence‐based multidisciplinary managementJournal of Surgical Oncology, 2005
- Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcomaAnnals of Oncology, 2004
- Characterization of the Pseudocapsule of Soft-Tissue SarcomasClinical Orthopaedics and Related Research, 1989